BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 23999434)

  • 1. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
    Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
    J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis.
    Díaz-Jiménez D; Núñez L; De la Fuente M; Dubois-Camacho K; Sepúlveda H; Montecino M; Torres-Riquelme A; García-González P; Chnaiderman J; Vossenkamper A; MacDonald TT; Simian D; González MJ; Cidlowski JA; Quera R; Hermoso MA
    Sci Rep; 2017 Aug; 7(1):10180. PubMed ID: 28860510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
    Pusceddu I; Dieplinger B; Mueller T
    Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
    Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
    J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.
    Miller AM; Liew FY
    Pharmacol Ther; 2011 Aug; 131(2):179-86. PubMed ID: 21356240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature.
    Demyanets S; Kaun C; Pentz R; Krychtiuk KA; Rauscher S; Pfaffenberger S; Zuckermann A; Aliabadi A; Gröger M; Maurer G; Huber K; Wojta J
    J Mol Cell Cardiol; 2013 Jul; 60():16-26. PubMed ID: 23567618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic association of epithelial IL1RL1 to human TH2-like asthma.
    Traister RS; Uvalle CE; Hawkins GA; Meyers DA; Bleecker ER; Wenzel SE
    J Allergy Clin Immunol; 2015 Jan; 135(1):92-9. PubMed ID: 25091434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood.
    Savenije OE; Mahachie John JM; Granell R; Kerkhof M; Dijk FN; de Jongste JC; Smit HA; Brunekreef B; Postma DS; Van Steen K; Henderson J; Koppelman GH
    J Allergy Clin Immunol; 2014 Jul; 134(1):170-7. PubMed ID: 24568840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population.
    Queiroz GA; Costa RS; Alcantara-Neves NM; Nunes de Oliveira Costa G; Barreto ML; Carneiro VL; Figueiredo CA
    Int J Immunogenet; 2017 Apr; 44(2):51-61. PubMed ID: 28266165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension.
    Shao D; Perros F; Caramori G; Meng C; Dormuller P; Chou PC; Church C; Papi A; Casolari P; Welsh D; Peacock A; Humbert M; Adcock IM; Wort SJ
    Biochem Biophys Res Commun; 2014 Aug; 451(1):8-14. PubMed ID: 25003325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST2 and IL-33 in pregnancy and pre-eclampsia.
    Granne I; Southcombe JH; Snider JV; Tannetta DS; Child T; Redman CW; Sargent IL
    PLoS One; 2011; 6(9):e24463. PubMed ID: 21949719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble ST2--analytical considerations.
    Mueller T; Jaffe AS
    Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid increases soluble ST2 expression in mouse lung and human bronchial epithelial cells.
    Zhao J; Chen Q; Li H; Myerburg M; Spannhake EW; Natarajan V; Zhao Y
    Cell Signal; 2012 Jan; 24(1):77-85. PubMed ID: 21871564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.
    Reichenbach DK; Schwarze V; Matta BM; Tkachev V; Lieberknecht E; Liu Q; Koehn BH; Pfeifer D; Taylor PA; Prinz G; Dierbach H; Stickel N; Beck Y; Warncke M; Junt T; Schmitt-Graeff A; Nakae S; Follo M; Wertheimer T; Schwab L; Devlin J; Watkins SC; Duyster J; Ferrara JL; Turnquist HR; Zeiser R; Blazar BR
    Blood; 2015 May; 125(20):3183-92. PubMed ID: 25814531
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Gordon ED; Palandra J; Wesolowska-Andersen A; Ringel L; Rios CL; Lachowicz-Scroggins ME; Sharp LZ; Everman JL; MacLeod HJ; Lee JW; Mason RJ; Matthay MA; Sheldon RT; Peters MC; Nocka KH; Fahy JV; Seibold MA
    JCI Insight; 2016 Sep; 1(14):e87871. PubMed ID: 27699235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of altered IL-33/ST2 immune axis in the immunobiology of Guillain-Barré syndrome.
    Sharma PP; Seshagiri DV; Nagappa M; Mullapudi T; Sreenivas N; Dey S; Shivaram S; Wahatule R; Kumawat V; Sreekumaran Nair BV; Kamath S; Sinha S; Taly AB; Debnath M
    Eur J Neurol; 2022 Jul; 29(7):2074-2083. PubMed ID: 35322935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.
    Sweet MJ; Leung BP; Kang D; Sogaard M; Schulz K; Trajkovic V; Campbell CC; Xu D; Liew FY
    J Immunol; 2001 Jun; 166(11):6633-9. PubMed ID: 11359817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Effects of Weighted Genetic Risk Scores and Resistin and sST2 Levels on the Prognostication of Long-Term Outcomes in Patients with Coronary Artery Disease.
    Chou HH; Hsu LA; Juang JJ; Chiang FT; Teng MS; Wu S; Ko YL
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble ST2, a modulator of the inflammatory response, in preterm and term labor.
    Stampalija T; Chaiworapongsa T; Romero R; Tarca AL; Bhatti G; Chiang PJ; Than NG; Ferrazzi E; Hassan SS; Yeo L
    J Matern Fetal Neonatal Med; 2014 Jan; 27(2):111-21. PubMed ID: 23688338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.